Vault-13

NEUPHORIA THERAPEUTICS INC NEUP

COM · Common Stock · CUSIP 64136E102

10 institutional holders +2 vs Q1 2025
177,963178.0k shares reported held*
9.5% of all shares outstanding*
$1.3mreported value*
2 new 1 added 2 reduced 0 sold out net bought ≈ $105.4k (+14.8k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 1.9m as of 2025-05-16, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $7.10.

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

0510Q4 24: 9Q1 25: 8Q2 25: 1010Q4 24Q1 25Q2 25
Numbers
QuarterHolders
Q4 20249
Q1 20258
Q2 202510

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
505Q1 25: 3 bought or addedQ1 25: 5 cut or sold outQ1 25Q2 25: 3 bought or addedQ2 25: 2 cut or sold outQ2 25
Numbers
QuarterBought or addedCut or sold out
Q1 202535
Q2 202532

Biggest buyers

Biggest sellers

AdvisorShares Investments LLC Reduced -1,926-1.9k
RHUMBLINE ADVISERS Reduced -382-382

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Lynx1 Capital Management LP 13D · may seek influence no change · filed 2025-12-29
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On December 26, 2025, the Reporting Persons made an offer to the Board to acquire, through one or more managed investment funds and vehicles affiliated with the Investment Manager, certain intellectual-property-related assets of the Company in an all-cash transaction, or if the Company prefers, through the delivery by the Reporting Persons to the Company of shares of Common Stock of the Company with equivalent value (the "IP Rights Proposal"). The IP Rights Proposal is subject to the Reporting Persons' due diligence and agreement on definitive documentation for the acquisition. Neither the Reporting Persons nor the Company is obligated to complete a transaction in connection with the IP Rights Proposal, and th… Full filing
16.3% no change 875.3k≈ $3.8m 2025-12-29
Shay Capital LLC 13G · passive investor new · filed 2025-10-31 7.3% new 171.6k≈ $750.0k 2025-10-31
AdvisorShares Trust 13G · institution new · filed 2026-10-05 5.8% new 312.9k≈ $1.4m 2026-10-05

Fell to 5% or below in the last year: Coastlands Capital LP (4.2%, 2026-07-28), Baselake Partners, LP (4.1%, 2026-02-06)

Insider purchases and sales in Q2 2025

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q2 2025.

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 AdvisorShares Investments LLC 0.09% of their portfolio BETHESDA, MD 67,73367.7k $480.9k $480.9k 0.09% Reduced -1.9k -1,926
2 Lynx1 Capital Management LP 0.09% of their portfolio DORADO, PR 45,80645.8k $325.2k $325.2k 0.09% Unchanged
3 Prosperity Wealth Management, Inc. 0.08% of their portfolio San Ramon, CA 29,75029.8k $211.2k $211.2k 0.08% Added +2.5k +2,550
4 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 14,60614.6k $103.7k $103.7k 0.00% New
5 Merck & Co., Inc. 0.03% of their portfolio RAHWAY, NJ 10,02710.0k $71.2k $71.2k 0.03% Unchanged
6 Cyndeo Wealth Partners, LLC 0.00% of their portfolio ST. PETERSBURG, FL 10,00010.0k $71.0k $71.0k 0.00% Unchanged
7 RHUMBLINE ADVISERS 0.00% of their portfolio BOSTON, MA 3333 $234 $234 0.00% Reduced -382 -382
8 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 77 $50 $50 0.00% Unchanged
9 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 11 $7 $7 0.00% New
10 CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio BIRMINGHAM, AL 00 $0 $0 — Unchanged